"Designing Growth Strategies is in our DNA"

Diabetes Drugs Market Size, Share and Industry Analysis By Drug Class (Insulin, DPP-4 Inhibitors, GLP-1 Receptor Agonists, SGLT2 Inhibitors), Diabetes Type (Type 1, Type 2), Route of Administration (Oral, Subcutaneous, Intravenous), Distribution Channel (Online pharmacies, Hospital Pharmacies, Retail Pharmacies) & Regional Forecast 2019 - 2026

Region : Global | Format: PDF | Report ID: FBI100570

 

Table of Content:

1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

4. Key Insights

4.1 Prevalence of Diabetes - For Key Countries, 2018

4.2 Pipeline Analysis

4.3 Key Industry Developments –Mergers, Acquisitions and Partnerships

4.4 Introduction of New Drugs/Approvals (by major players)

4.5 Overview of Regulatory Scenario of Key Countries/ Regions

5. Global Diabetes Drugs Market Analysis, Insights and Forecast, 2015-2026

5.1. Key Findings / Summary

5.2. Market Analysis, Insights and Forecast – By Drug Class

5.2.1 Insulin

5.2.2 DPP-4 Inhibitors

5.2.3 GLP-1 Receptor Agonists

5.2.4 SGLT2 Inhibitors

5.2.5 Others

5.3. Market Analysis, Insights and Forecast – By Diabetes Type

5.3.1 Diabetes 1

5.3.2 Diabetes 2

5.4 Market Analysis, Insights and Forecast – By Route of Administration

5.4.1 Oral

5.4.2 Subcutaneous

5.4.3 Intravenous

5.5. Market Analysis, Insights and Forecast – By Distribution Channel

5.5.1 Online pharmacies

5.5.2 Hospital Pharmacies

5.5.3 Retail Pharmacies

5.6. Market Analysis, Insights and Forecast – By Region

5.6.1 North America

5.6.2 Europe

5.6.3 Asia Pacific

5.6.4 Latin America

5.6.5 Middle East & Africa

6. North America Diabetes Drugs Market Analysis, Insights and Forecast, 2015-2026

6.1. Key Findings / Summary

6.2. Market Analysis, Insights and Forecast – By Drug Class

6.2.1 Insulin

6.2.2 DPP-4 Inhibitors

6.2.3 GLP-1 Receptor Agonists

6.2.4 SGLT-2 Inhibitors

6.2.5 Others

6.3. Market Analysis, Insights and Forecast – By Diabetes Type

6.3.1 Diabetes 1

6.3.2 Diabetes 2

6.4. Market Analysis, Insights and Forecast – By Route of Administration

6.4.1 Oral

6.4.2 Subcutaneous

6.4.3 Intravenous

6.5. Market Analysis, Insights and Forecast – By Distribution Channel

6.5.1 Online pharmacies

6.5.2 Hospital Pharmacies

6.5.3 Retail Pharmacies

6.6. Market Analysis, Insights and Forecast – By Country

6.6.1 U.S.

6.6.2 Canada

7. Europe Diabetes Drugs Market Analysis, Insights and Forecast, 2015-2026

7.1. Key Findings / Summary

7.2. Market Analysis, Insights and Forecast – By Drug Class

7.2.1 Insulin

7.2.2 DPP-4 Inhibitors

7.2.3 GLP-1 Receptor Agonists

7.2.4 SGLT-2 Inhibitors

7.2.5 Others

7.3. Market Analysis, Insights and Forecast – By Diabetes Type

7.3.1 Diabetes 1

7.3.2 Diabetes 2

7.4. Market Analysis, Insights and Forecast – By Route of Administration

7.4.1 Oral

7.4.2 Subcutaneous

7.4.3 Intravenous

7.5. Market Analysis, Insights and Forecast – By Distribution Channel

7.5.1 Online pharmacies

7.5.2 Hospital Pharmacies

7.5.3 Retail Pharmacies

7.6. Market Analysis, Insights and Forecast – By Country/ Sub-region

7.6.1 UK

7.6.2 Germany

7.6.3 France

7.6.4 Italy

7.6.5 Spain

7.6.6 Scandinavia

7.6.7 Rest of Europe

8. Asia Pacific Diabetes Drugs Market Analysis, Insights and Forecast, 2015-2026

8.1. Key Findings / Summary

8.2. Market Analysis, Insights and Forecast – By Drug Class

8.2.1 Insulin

8.2.2 DPP-4 Inhibitors

8.2.3 GLP-1 Receptor Agonists

8.2.4 SGLT-2 Inhibitors

8.2.5 Others

8.3. Market Analysis, Insights and Forecast – By Diabetes Type

8.3.1 Diabetes 1

8.3.2 Diabetes 2

8.4. Market Analysis, Insights,and Forecast – By Route of Administration

8.4.1 Oral

8.4.2 Subcutaneous

8.4.3 Intravenous

8.5. Market Analysis, Insights and Forecast – By Distribution Channel

8.5.1 Online pharmacies

8.5.2 Hospital Pharmacies

8.5.3 Retail Pharmacies

8.6. Market Analysis, Insights and Forecast – By Country/ Sub-region

8.6.1 China

8.6.2 India

8.6.3 Japan

8.6.4 Australia

8.6.5 South East Asia

8.6.6 Rest of Asia Pacific

9. Latin America Diabetes Drugs Market Analysis, Insights and Forecast, 2015-2026

9.1. Key Findings / Summary

9.2. Market Analysis, Insights and Forecast – By Drug Class

9.2.1 Insulin

9.2.2 DPP-4 Inhibitors

9.2.3 GLP-1 Receptor Agonists

9.2.4 SGLT-2 Inhibitors

9.2.5 Others

9.3. Market Analysis, Insights and Forecast – By Diabetes Type

9.3.1 Diabetes 1

9.3.2 Diabetes 2

9.4. Market Analysis, Insights and Forecast – By Route of Administration

9.4.1 Oral

9.4.2 Subcutaneous

9.4.3 Intravenous

9.5. Market Analysis, Insights and Forecast – By Distribution Channel

9.5.1 Online pharmacies

9.5.2 Hospital Pharmacies

9.5.3 Retail Pharmacies

9.6. Market Analysis, Insights and Forecast – By Country/ Sub-region

9.6.1 Brazil

9.6.2 Mexico

9.6.3 Rest of Latin America

10. Middle East &Africa Diabetes Drugs Market Analysis, Insights and Forecast, 2015-2026

10.1. Key Findings / Summary

10.2. Market Analysis, Insights and Forecast – By Drug Class

10.2.1 Insulin

10.2.2 DPP-4 Inhibitors

10.2.3 GLP-1 Receptor Agonists

10.2.4 SGLT-2 Inhibitors

10.2.5 Others

10.3. Market Analysis, Insights,and Forecast – By Diabetes Type

10.3.1 Diabetes 1

10.3.2 Diabetes 2

10.4. Market Analysis, Insights,and Forecast – By Route of Administration

10.4.1 Oral

10.4.2 Subcutaneous

10.4.3 Intravenous

10.5. Market Analysis, Insights,and Forecast – By Distribution Channel

10.5.1 Online pharmacies

10.5.2 Hospital Pharmacies

10.5.3 Retail Pharmacies

10.6. Market Analysis, Insights,and Forecast – By Country/ Sub-region

10.6.1 GCC

10.6.2 South Africa

10.6.3 Rest of Middle East and Africa

11. Competitive Analysis

11.1. Key Industry Developments

11.2. Global Market Share Analysis (2018)

11.3. Company Profiles (Overview,Products & services, SWOT analysis, Recent developments, strategies,financials (based on availability))

11.3.1 Novo Nordisk India Pvt Ltd

11.3.2 Sanofi

11.3.3 Merck& Co., Inc.

11.3.4 Eli Lilly and Company.

11.3.5 Astra Zeneca

11.3.6 Takeda Pharmaceutical Company Limited

11.3.7 Boehringer Ingelheim International GmbH

11.3.8 Novartis AG

11.3.9 Johnson & Johnson Services, Inc.

11.3.10 Bayer AG

11.3.11 Other Players

 class=
  • Jun, 2019
  • 2018
  • 2015-2017
  • 150

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X